Masimo SafetyNet Opioid System gets marketing authorisation from FDA
Masimo has received marketing authorisation from the US FDA for its SafetyNet Opioid System, an anti-opioid-overdosing device.
Masimo has received marketing authorisation from the US FDA for its SafetyNet Opioid System, an anti-opioid-overdosing device.
Phase II trial misses main goal, but drugmaker set to forge ahead
Show Critical Care Time, Ep 24. Thrombocytopenia with Dr. Matthew Rendo, MD. – May 20, 2024
This randomized trial assesses whether acetaminophen would increase the number of days alive and free of organ support to day 28 among critically ill patients…
Your study has timed out. Please make sure that you allow cookies from our site. Alternatively, this could occur if you spend more than 15…
This randomized trial assesses whether acetaminophen would increase the number of days alive and free of organ support to day 28 among critically ill patients…
This cross-sectional study assesses patient preferences for various visual backgrounds during telemedicine video visits.
27.2K likes, 314 comments. “Lizard intubation, Bitches!”
Neurocritical Care – Elevated intracranial pressure (ICP) is a neurological emergency in patients with acute brain injuries. Such a state requires immediate and effective interventions…
(Bloomberg) — When Oracle Corp. spent $28 billion two years ago to acquire electronic-records company Cerner Corp., it promised a revolution in health care technology.…
Anti-vaccine activist RFK Jr said he also suffered mercury poisoning from eating too much fish: ‘I loved tuna fish sandwiches. I ate them all the…